1. Expression of a recombinant anti-programed cell death 1 antibody in the mammary gland of transgenic mice.
- Author
-
Gong, Guihua, Zhang, Wei, Xie, Liping, Xu, Lei, Han, Shu, and Hu, Youjia
- Subjects
- *
TRANSGENIC mice , *CELL death , *RECOMBINANT antibodies , *TRANSGENIC animals , *ANTIBODY formation , *MONOCLONAL antibodies , *MAMMARY glands - Abstract
Nivolumab, a fully human IgG4 anti-programed cell death 1(PD-1)antibody, is recently one of the most popular and successful therapeutic monoclonal antibodies in clinical use. With the increasing demands for Nivolumab and other therapeutic monoclonal antibodies, the mammary gland bioreactor has been regarded as another choice for the production of recombinant monoclonal antibodies besides mammalian cell culture. Here, we expressed a recombinant human anti-PD-1 antibody in the mammary glands of transgenic mice. Two expression vectors were constructed bearing the heavy and light chains of anti-PD-1 antibody respectively under the control of bovine αs1-casein promoter. Transgenic mice were then generated by co-microinjection of the two expression cassettes. Three F0 founders with both heavy chain and light chain positive were obtained. Transgenes of both chains were detected to be stably transmitted to the offspring. The recombinant antibody was detected in the milk of transgenic mice with the highest expression level up to 80.52 ± 0.82 mg/L and could specifically binds to the human PD-1 antigen. Therefore, our results suggest the feasibility of anti-PD-1 antibody production in the milk of transgenic animals. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF